Searched for
ASHISH LIFE SCIENCE
Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...- India reels under severe heatwave, Delhi records temperature of 44.5 degrees CelsiusIndia is experiencing intense heatwave conditions with temperatures soaring across several states, including Delhi, Uttar Pradesh, Bihar, R...
- Elmed Life Sciences raises $2.7 million from Nabard-backed Agrisure FundElmed Life Sciences has raised $2.7 million from Agrisure Fund, which is managed by Nabard-backed Nabventures. The company develops and man...
- Rx Propellant commits $100 million to build India’s largest life sciences campus in HyderabadRx Propellant will invest $100 million in Hyderabad's Genome Valley. A new life sciences campus will be built over six years. This project ...
- Vishal Mega Mart vs Mobikwik vs Sai Life Sciences: Which IPO is expected to give highest listing gains going by GMP?It's raining debuts on D-Street as three companies --Vishal Mega Mart, Mobikwik and Sai Life Sciences -- will see their shares listed on th...
- Camlin Fine Sciences shares jump over 6% on open offer newsThe open offer to acquire over 44,560,177 (4.45 crore) equity shares constituting 26% stake of Camlin Fine Sciences augurs well for the com...
- Actis to invest over $700 million to develop life sciences realty assets in IndiaIndia has been attracting a lot of global R&D work in the life sciences sector in the backdrop of an abundant high quality talent pool, and...
- Actis acquires life sciences realty platform RX Propellant, to invest $200 millionRx Propellant is involved in development and marketing of several real estate projects in design-development stage across Hyderabad and Ban...
- Doceree raises $11 million from Eight Roads Ventures, othersDoceree will use the funds to scale its global operations, expand partnerships, augment its product portfolio and advance the platform’s me...
- Doceree closes $11 million funding round led by Eight Roads VenturesDoceree plans to use the capital to expand its global operations, expand partnerships, extend its product offering, and improve the platfor...
- Lakhimpur Kheri violence: Weapon seized from Union minister's son was fired, confirms FSL reportThe special investigation team (SIT) probing the case is yet to issue an official statement on the FSL report.
- HappyPlus Consulting gets angel funding from Dubai-based investorThe six-months-old startup provides its services to firms such as Tata Steel LP division, TM International (Logistics) and Mahanagar Gas, a...
- How did Jhujhunwala, Kacholia, Vijay Kedia & others fare in 2020Kacholia emerged the biggest gainer among the aforementioned investors. His equity portfolio was valued at Rs 1,015 crore as of December 31...
- SRF to sell engineering plastics business to DSM for Rs 320 crThe company has entered into a definitive agreement to sell its engineering plastics business to DSM.
- Eight Roads leads Rs 92-cr round in digital company WhatfixFor Eight Roads, the investment in Whatfix is the latest by the investment firm in 2019. In January, it had led a Rs 45-crore round in vete...
- Eight Roads leads Rs 45 crore Series A funding round in Ashish Life ScienceThe investment is the second by the marquee investor in India's broader pharmaceutical sector.
- On Urban Ladder CEO Ashish Goel's bookshelf: Robert Ludlum, Roald Dahl, and Neil GaimanThis top boss reads for an hour every day before bedtime.
- Buy Camlin Fine Sciences, target Rs 100: Kunal BothraBuy Camlin Fine Sciences at a price target of Rs 100 and a stop loss at Rs 83 from entry point.
- Buy Camlin Fine Sciences, target Rs 85: Swati HotkarBuy Camlin Fine Sciences at a price target of Rs 85 and a stop loss at Rs 75 from entry point.
- GE to open validation lab in BangaloreGE today announced launch of a state-of-the-art validation laboratory in Bangalore which will support repair and calibration of Kaye range ...
Load More
